Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Solid Neoplasms × Platinum × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 32 Lung Neoplasms 18 Squamous Cell Carcinoma of Head and Neck 17 Small Cell Lung Carcinoma 16 Uterine Cervical Neoplasms 15 Ovarian Neoplasms 10 Oropharyngeal Neoplasms 10 Carcinoma 9 Urinary Bladder Neoplasms 8 Mouth Neoplasms 8 Laryngeal Neoplasms 8 Hypopharyngeal Neoplasms 8 Fallopian Tube Neoplasms 8 Stomach Neoplasms 7 Nasopharyngeal Carcinoma 6 Mesothelioma, Malignant 6 Breast Neoplasms 6 Adenocarcinoma of Lung 6 Triple Negative Breast Neoplasms 5 Pancreatic Neoplasms 5 Medulloblastoma 5 Cholangiocarcinoma 5 Prostatic Neoplasms 4 Neuroblastoma 4 Ganglioneuroblastoma 4 Gallbladder Neoplasms 4 Esophageal Neoplasms 4 Brain Neoplasms 4 Vulvar Neoplasms 3 Urethral Neoplasms 3

Interventions

pembrolizumab 2 Platinum 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04420884 2025-06-13

iintune-1

Takeda

Phase 1/2 Active not recruiting

Solid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡